Intestat

Ezetimibe, the active ingredient in Intestat, is a cholesterol absorption inhibitor presented as an oral dosage form for oral use. It lowers elevated cholesterol levels and is used in patients with hypercholesterolemia, heterozygous familial hypercholesterolemia, and primary hyperlipidemia. GNH USA supplies Intestat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Intestat works by targeting cholesterol metabolism and is indicated for the following conditions: - Hypercholesterolemia: reduces low‑density lipoprotein (LDL) cholesterol levels. - Heterozygous familial hypercholesterolemia: helps achieve target LDL reductions in genetically predisposed patients. - Primary hyperlipidemia: lowers elevated lipid concentrations as part of a comprehensive lipid‑lowering regimen.

Intestat is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain in the head region. - Abdominal pain: discomfort or cramping in the stomach area. - Diarrhea: loose, watery stools. - Fatigue: feeling unusually tired. - Myalgia: muscle aches or soreness. - Elevated liver enzymes: mild increase in hepatic enzyme levels.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown that can lead to kidney injury. - Severe liver injury: marked elevation of liver enzymes or jaundice. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain and nausea.

Before initiating therapy with Intestat, consider the following precautions: - Liver function monitoring: assess baseline hepatic enzymes and repeat as needed. - Baseline lipid assessment: confirm diagnosis and set treatment goals. - Combination with statins: use cautiously and monitor for muscle toxicity. - Active liver disease: avoid use in patients with known hepatic impairment. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Intestat may interact with other medications; awareness of these interactions helps maintain safety and efficacy.

Major Interactions (Avoid): - Cholestyramine, colestipol, colesevelam: these bile‑acid sequestrants bind ezetimibe and markedly reduce its absorption. - Cyclosporine: may increase ezetimibe plasma concentrations.

Moderate Interactions (Monitor Closely): - High‑dose statins: combined use can raise the risk of myopathy. - Fibrates: may increase the likelihood of muscle‑related side effects. - Warfarin: monitor INR values as ezetimibe may affect anticoagulant control.